455 related articles for article (PubMed ID: 23839159)
21. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
[TBL] [Abstract][Full Text] [Related]
22. γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma.
Ma H; Zhang L; Tang B; Wang Y; Chen R; Zhang B; Chen Y; Ge N; Wang Y; Gan Y; Ye S; Ren Z
Ann Surg Oncol; 2014 Sep; 21(9):3084-9. PubMed ID: 24748164
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
24. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
[TBL] [Abstract][Full Text] [Related]
27. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
28. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases.
Zhu HF; Li J; Huang L; Yan YQ
Hepatogastroenterology; 2013; 60(122):263-7. PubMed ID: 23574653
[TBL] [Abstract][Full Text] [Related]
29. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
30. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
[TBL] [Abstract][Full Text] [Related]
31. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
[TBL] [Abstract][Full Text] [Related]
32. Treatment of recurrent intrahepatic cholangiocarcinoma.
Sulpice L; Rayar M; Boucher E; Pracht M; Meunier B; Boudjema K
Br J Surg; 2012 Dec; 99(12):1711-7. PubMed ID: 23132419
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
[TBL] [Abstract][Full Text] [Related]
34. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
[TBL] [Abstract][Full Text] [Related]
35. Role of major vascular resection in patients with intrahepatic cholangiocarcinoma.
Ali SM; Clark CJ; Zaydfudim VM; Que FG; Nagorney DM
Ann Surg Oncol; 2013 Jun; 20(6):2023-8. PubMed ID: 23263702
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients.
Fu XH; Tang ZH; Zong M; Yang GS; Yao XP; Wu MC
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):279-83. PubMed ID: 15138126
[TBL] [Abstract][Full Text] [Related]
37. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
[TBL] [Abstract][Full Text] [Related]
38. Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer.
Polterauer S; Hofstetter G; Grimm C; Rahhal J; Mailath-Pokorny M; Kohl M; Concin N; Tempfer C; Marth C; Reinthaller A
Gynecol Oncol; 2011 Sep; 122(3):590-4. PubMed ID: 21664662
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]